(Q45328468)

13 December 2017

title

Repeat administration of proteins to the eye with a single intraocular injection of an adenovirus vector (English)

1 reference

13 December 2017

1 reference

Duncan McVey

1

1 reference

13 December 2017

Melissa M Hamilton

2

1 reference

13 December 2017

Chi Hsu

3

1 reference

13 December 2017

C Richter King

4

1 reference

13 December 2017

Douglas E Brough

5

1 reference

13 December 2017

Lisa L Wei

6

1 reference

13 December 2017

publication date

10 June 2008

1 reference

13 December 2017

1 reference

13 December 2017

volume

16

1 reference

13 December 2017

issue

8

1 reference

13 December 2017

page(s)

1444-1449

1 reference

A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Efficiency of different viral promoters in directing gene expression in mammalian cells: effect of 3'-untranslated sequences

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

https://api.crossref.org/works/10.1038%2FMT.2008.124

1 reference

7 January 2021

An immune response after intraocular administration of an adenoviral vector containing a beta galactosidase reporter gene slows retinal degeneration in the rd mouse

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Intravitreal adenoviral gene transfer evokes an immune response in the retina that is directed against the heterologous lacZ transgene product but does not limit transgene expression

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Repeated administration of adenovector in the eye results in efficient gene delivery

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Effective repeat administration with adenovirus vectors to the muscle

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Transcriptionally active drugs improve adenovirus vector performance in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

New pharmacologic approaches to therapy for age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: a review

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Induction of human gamma globin gene expression by histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Ocular immune privilege: therapeutic opportunities from an experiment of nature

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Classical and novel retinoids: their targets in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Evaluation of retinoic acid ophthalmic emulsion in dry eye.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Topical retinoid therapy for squamous metaplasia of various ocular surface disorders. A multicenter, placebo-controlled double-masked study

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Long-term clinical experience with a topical retinoid

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Workshop on long-term follow-up of participants in human gene transfer research

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Supplemental guidance on testing for replication-competent retrovirus in retroviral vector-based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Investigation on the photostability of a tretinoin lotion and stabilization with additives

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Periocular gene transfer of sFlt-1 suppresses ocular neovascularization and vascular endothelial growth factor-induced breakdown of the blood-retinal barrier

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Quantitative image analysis of laser-induced choroidal neovascularization in rat.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.124

7 January 2021

Identifiers

DOI

10.1038/MT.2008.124

1 reference

13 December 2017

1 reference